2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO
生物活性
Description
In Vivo
In Vitro
化合物的使用
Kinase Assay
Cell Assay
Animal Administration
参考文献
Pirarubicin is an anthracycline drug. An analogue of the anthracycline antineoplastic antibiotic doxorubicin. Pirarubicin intercalates into DNA and interacts with topoisomerase II, thereby inhibiting DNA replication and repair and RNA and protein synthesis. This agent is less cardiotoxic than doxorubicin and exhibits activity against some doxorubicin-resistant cell lines. For the detailed information of Pirarubicin(THP), the solubility of Pirarubicin(THP) in water, the solubility of Pirarubicin(THP) in DMSO, the solubility of Pirarubicin(THP) in PBS buffer, the animal experiment (test) of Pirarubicin(THP), the cell expriment (test) of Pirarubicin(THP), the in vivo, in vitro and clinical trial test of Pirarubicin(THP), the EC50, IC50,and affinity,of Pirarubicin(THP), For the detailed information of Pirarubicin(THP), the solubility of Pirarubicin(THP) in water, the solubility of Pirarubicin(THP) in DMSO, the solubility of Pirarubicin(THP) in PBS buffer, the animal experiment (test) of Pirarubicin(THP), the cell expriment (test) of Pirarubicin(THP), the in vivo, in vitro and clinical trial test of Pirarubicin(THP), the EC50, IC50,and affinity,of Pirarubicin(THP), Please contact DC Chemicals.
